MiniMed Group, Inc. Common Stock

MMED

Medical - Care Facilities · Healthcare

Winston Score

–

No score yet — Winston is napping.

We couldn’t gather enough financial data to score this stock reliably.

MiniMed Group is a medical technology company that makes insulin delivery systems for people with diabetes. Its main products are insulin pumps and continuous glucose monitors, which help patients automatically track and manage their blood sugar levels. The company competes in the diabetes care device market alongside larger players like Medtronic and Dexcom.

MiniMed earns revenue by selling its hardware devices and the disposable supplies patients need to keep using them, such as infusion sets and reservoirs, creating a recurring revenue stream. The company operates primarily in the United States but has been expanding into international markets. With a negative operating margin of nearly 20%, MiniMed is still spending heavily to grow, and its main challenge is competing against well-funded rivals with stronger brand recognition and broader distribution networks while working toward consistent profitability.

Winston Score History

Growth Profile

For growth stock investors

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

+15.6% YoY

Steady revenue growth

EPS Growth

EPS data limited

Insider Activity

90.0%ownership

→ Flat

Insiders holding steady — not selling despite ability to

Cash Runway

~4 months

$298M cash & investments

Quarterly Free Cash Flow

Short runway — potential dilution ahead through share issuance

Cash watch

MiniMed Group, Inc. Common Stock has less than a year of cash at its current burn rate. Growth investors should watch for potential share dilution from future fundraising — that directly reduces your ownership.

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Gross Margin

57.3%

Premium pricing power — 57.3% gross margin

Operating Margin

9.8%

Modest — 9.8% operating margin

ROCE

2.2%

Weak — 2.2% return on capital

ROIC between 0% and 5%. They earn a few cents back per dollar invested in the business.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales YoY

N/A

—

Data not available

EPS YoY

N/A

—

Data not available

EPS Consistency

N/A

—

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Cash Conversion

N/A

—

Data not available

FCF Margin

N/A

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

Debt / Equity

0.04

Conservative — low debt load (0.04)

Interest Cover

N/A

—

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

P/E Ratio (TTM)

N/M

no trend

Negative earnings — P/E not meaningful

P/E vs Forward

N/A

not available

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Not applicable for this business.

🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.

Start free trial